HYDRIX LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.015 AUD | -6.25% |
|
-6.25% | -21.05% |
| 02-28 | Hydrix Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
| 2023 | Hydrix Limited Reports Earnings Results for the Full Year Ended June 30, 2023 | CI |
| Sales 2022 | 10.46M 6.83M 9.33M | Sales 2023 | 13.16M 8.59M 11.74M | Capitalization | 6.61M 4.32M 5.9M |
|---|---|---|---|---|---|
| Net income 2022 | -5M -3.27M -4.46M | Net income 2023 | - 0 0 | EV / Sales 2022 | 1.73 x |
| Net Debt 2022 | 3.46M 2.26M 3.09M | Net Debt 2023 | 3.58M 2.34M 3.19M | EV / Sales 2023 | 0.77 x |
| P/E ratio 2022 |
-2.32
x | P/E ratio 2023 |
-15.3
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 58.47% |
More Fundamentals
* Assessed data
More news
| 1 day | -6.25% | ||
| 1 week | -6.25% | ||
| Current month | -16.67% | ||
| 1 month | -16.67% | ||
| 3 months | -28.57% | ||
| 6 months | -28.57% | ||
| Current year | -21.05% |
1 week
0.01
0.02
1 month
0.010.02
Current year
0.010.02
1 year
0.010.04
3 years
0.010.29
5 years
0.010.81
10 years
0.015.45
| Managers | Title | Age | Since |
|---|---|---|---|
Vickie Edwards
COO | Chief Operating Officer | - | 21-03-31 |
Robert Brierley
HRO | Human Resources Officer | - | 21-07-31 |
Alan Morris
SAM | Sales & Marketing | - | 18-08-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 21-10-27 | |
Paul Wright
BRD | Director/Board Member | 59 | 18-08-07 |
Gavin Coote
CHM | Chairman | - | 17-01-11 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 0.015 | -6.25% | 377,329 |
| 24-04-23 | 0.016 | 0.00% | 39,750 |
| 24-04-19 | 0.016 | 0.00% | 4,341 |
| 24-04-18 | 0.016 | 0.00% | 210,490 |
Delayed Quote Australian S.E., April 26, 2024 at 01:35 am
More quotes
Hydrix Limited is an Australia-based specialist product designing, engineering and medical device distribution company. The Company is engaged in the development of comprehensive products. Its segments include Hydrix Services, Hydrix Medical and Hydrix Ventures. Hydrix Services segment offers a comprehensive range of engineering, development and regulatory consulting services, including software, electronics, mechanical, industrial design and general product development services. Hydrix Medical distributes disruptive cardiovascular technologies that address unmet needs of patients and healthcare providers. Products include the Guardian real-time heart attack warning system from Avertix Medical, Implicityâs cloud-based artificial intelligence (AI)-driven remote cardiac patient monitoring and data management solution, and Echo IQâs AI technology. Hydrix Services segmentâs portfolio companies include Gyder Surgical Pty Ltd, Avertix Medical Inc., Memphasys Limited, and Cyban Pty Ltd.
Sector
Business Support Services
Calendar
2024-08-26
- Q4 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -21.05% | 2.49M | |
| +10.55% | 67.6B | |
| +11.64% | 18.21B | |
| +21.03% | 13.41B | |
| +9.40% | 13.37B | |
| +16.53% | 9.94B | |
| -32.90% | 5.74B | |
| -10.98% | 5.57B | |
| -4.09% | 4.91B | |
| -4.83% | 4.87B |
- Stock Market
- Equities
- HYD Stock
